2.6.1.45	additional information	not inhibited with or without NH4+ by oxalate, formate, acetaldehyde, pyruvate, hydroxypyruvate, 2-oxoglutarate	2	
2.6.1.45	additional information	not inhibited by NaBH4, 3-chloro-D-alanine, 1,10-phenanthroline, 2,2'-dipyridyl, 8-hydroxyquinoline, EDTA, iodoacetate, FeCl3, AlCl3, CdCl2, CoCl2, NiCl2, CaCl2, NaN3, ZnCl2, PbCl2, LiCl, CuCl2, BaCl2, ascorbate, cysteamine, N-ethylmaleimide	2	
2.6.1.45	additional information	not inhibited by 5,5'-dithio-bis(2-nitrobenzoate)	2	
2.6.1.45	pyruvate	competitive vs. glyoxylate	31	
2.6.1.45	2-oxoglutarate	2-oxoglutarate at a concentration above 12.5 mM inhibits enzyme SgaBath in the serine-2-oxoglutarate aminotransferase (SKAT) reaction, but has no effect on the serine-glyoxylate aminotranferase (SGAT) reaction, substrate inhibition	34	
2.6.1.45	2-oxoglutarate	2-oxoglutarate at a concentration above 12.5 mM inhibits enzyme Sga20Z in the serine-2-oxoglutarate aminotransferase (SKAT) reaction, but has no effect on the serine-glyoxylate aminotranferase (SGAT) reaction, substrate inhibition	34	
2.6.1.45	p-chloromercuribenzoate	1 mM, 37% inhibition	43	
2.6.1.45	p-chloromercuribenzoate	-	43	
2.6.1.45	N-ethylmaleimide	1 mM, 41% inhibition	49	
2.6.1.45	N-ethylmaleimide	-	49	
2.6.1.45	N-ethylmaleimide	weak, but significant inhibition	49	
2.6.1.45	NH4+	reversible inhibition	54	
2.6.1.45	NH4+	-	54	
2.6.1.45	iodoacetamide	-	67	
2.6.1.45	glycine	competitive vs. L-serine	72	
2.6.1.45	hydroxylamine	0.01 mM, 98% inhibition of serine-glyoxylate transamination	85	
2.6.1.45	hydroxylamine	0.01 mM, 85% inhibition of glycin-hydroxypyruvate transamination	85	
2.6.1.45	hydroxylamine	0.1 mM, 97% inhibition, 85% inhibition in the presence of 0.1 mM pyridoxal phosphate	85	
2.6.1.45	hydroxylamine	0.002 mM, 92% inhibition, serine, L-alanine and glycine protect	85	
2.6.1.45	hydroxylamine	-	85	
2.6.1.45	hydroxylamine	0.1 mM, 70% inhibition	85	
2.6.1.45	L-serine	competitive vs. asparagine	95	
2.6.1.45	p-hydroxymercuribenzoate	-	98	
2.6.1.45	p-hydroxymercuribenzoate	weak but significant inhibition	98	
2.6.1.45	p-hydroxymercuribenzoate	the 24.1% decrease in enzyme activity achieved using 1.0 mM inhibitor might be considered to be unspecific	98	
2.6.1.45	glyoxylate	competitive vs. pyruvate	101	
2.6.1.45	glyoxylate	irreversible inhibition only in the presence of NH4+, inactivation in the absence of amino acid substrates	101	
2.6.1.45	glyoxylate	amino acid substrates partially protect	101	
2.6.1.45	glyoxylate	presence of D-serine protects against inhibition	101	
2.6.1.45	glyoxylate	inhibited by glyoxylate above 6 mM	101	
2.6.1.45	L-alanine	competitive vs. L-serine	103	
2.6.1.45	HgCl2	strong inhibition	110	
2.6.1.45	formaldehyde	glyoxylate protects	130	
2.6.1.45	KCN	weak inhibition	161	
2.6.1.45	oxalate	competitive vs. 2-oxomalonate, uncompetitive vs. L-serine	185	
2.6.1.45	MgCl2	weak inhibition	196	
2.6.1.45	NaF	weak inhibition	235	
2.6.1.45	L-asparagine	competitive vs. serine	266	
2.6.1.45	NH4Cl	0.1 mM, 42% inhibition, 10 mM, complete inhibition	329	
2.6.1.45	NH4Cl	glycine-hydroxypyruvate transamination is only weakly inhibited	329	
2.6.1.45	NH4Cl	competitive vs. L-serine	329	
2.6.1.45	AgNO3	strong inhibition	360	
2.6.1.45	Semicarbazide	-	382	
2.6.1.45	phenylhydrazine	weak inhibition	398	
2.6.1.45	(NH4)2SO4	0.05 mM, 45% inhibition, 5 mM, complete inhibition	399	
2.6.1.45	D-serine	competitive inhibition	481	
2.6.1.45	D-serine	competitive inhibition with L-serine	481	
2.6.1.45	Aminooxyacetate	1 mM, complete inhibition	1374	
2.6.1.45	Aminooxyacetate	competitive inhibition	1374	
2.6.1.45	Aminooxyacetate	reacts with the carbonyl group of pyridoxal phosphate, 88% inhibition at 0.01 mM	1374	
2.6.1.45	beta-chloro-L-alanine	reacts with the carbonyl group of pyridoxal phosphate. 53.9% inhibition at 1 mM	1641	
2.6.1.45	Isonicotinic acid hydrazide	0.1 mM, 20% inhibition	2409	
2.6.1.45	Penicillamine	weak inhibition	2496	
2.6.1.45	cycloserine	weak inhibition	2837	
2.6.1.45	3-chloro-L-alanine	-	3967	
2.6.1.45	beta-chloroalanine	competitive vs. L-alanine, uncompetitive vs. 2-oxomalonate	5134	
2.6.1.45	ammonium acetate	0.1 mM, 42% inhibition, 10 mM, complete inhibition	9097	
2.6.1.45	SH-group inhibitor	-	114430